| Ms Yvette L Young, LCSW-C | |
|
7800 Central Ave, Landover, MD 20785-4807 | |
| (240) 418-7686 | |
| (866) 576-0581 |
| Full Name | Ms Yvette L Young |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 7800 Central Ave, Landover, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891133591 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | LC303576 (District Of Columbia) | Secondary |
| 1041C0700X | Social Worker - Clinical | 10104 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Yvette L Young, LCSW-C 7800 Central Ave, Landover, MD 20785-4807 Ph: (240) 389-3558 | Ms Yvette L Young, LCSW-C 7800 Central Ave, Landover, MD 20785-4807 Ph: (240) 418-7686 |
News Archive
Researchers have confirmed for the first time the benefit of an innate defense system present in the few patients who remain healthy after years of infection with HIV despite receiving no treatment, according to an article published in the September edition of the Journal of Virology.
In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson's disease psychosis - a symptom of the progressive nervous system disorder in which patients experience hallucinations and delusions - researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system, concluding that the new drug, pimavanserin, did not pose a statistically significant greater risk of death.
Regeneron and Sanofi today announced that the European Medicines Agency has accepted for review the Marketing Authorization Application for Praluent (alirocumab). Alirocumab is an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9) that is intended for the treatment of patients with hypercholesterolemia.
Scientists and physicians at University of California San Diego School of Medicine, working with colleagues at the U.S. Navy Medical Research Center - Biological Defense Research Directorate, Texas A&M University, a San Diego-based biotech and elsewhere, have successfully used an experimental therapy involving bacteriophages - viruses that target and consume specific strains of bacteria - to treat a patient near death from a multidrug-resistant bacterium.
› Verified 4 days ago
Kamika Pope, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1103 Consideration Ln, Landover, MD 20785 Phone: 443-414-4619 | |
Theodore Michener, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 903 Brightseat Rd, Landover, MD 20785 Phone: 301-333-2980 | |
Eboni Henry, LGSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 411 Warfield Dr, Apt 3008, Landover, MD 20785 Phone: 706-340-6521 | |
Anita Lewis, LCSWC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8181 Professional Pl Ste 200, Landover, MD 20785 Phone: 301-306-4590 Fax: 301-880-0054 | |
Mrs. Regina Miller Nadir, LCSW-C, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 8201 Corporate Dr Ste 500, Landover, MD 20785 Phone: 301-758-7058 Fax: 301-218-7358 | |
Pauline Boldin, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8100 Professional Pl Ste 200, Landover, MD 20785 Phone: 301-577-4470 | |
Marissa Frumento, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6501 Columbia Park Rd, Landover, MD 20785 Phone: 301-925-1360 |